During Monday’s Morning trade, Shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX), lost -9.42% to $103.48.
Valeant Pharmaceuticals International, declared that chairman and chief executive officer J. Michael Pearson will be on a medical leave of absence, effective right away. The company’s board of directors has created an Office of the Chief Executive Officer, which will comprise Robert Chai-Onn, Executive Vice President and General Counsel, Dr. Ari Kellen, Executive Vice President and Company Group Chairman, and Robert Rosiello, Executive Vice President and Chief Financial Officer, to serve in an interim capacity.
In addition, the Board of Directors has created a Committee to oversee and support the Office of the CEO and will comprise Robert A. Ingram, Lead Independent Director, G. Mason Morfit, President, ValueAct Capital, and Howard B. Schiller, former Chief Financial Officer for Valeant.
Valeant confirmed last week that Mr. Pearson had recently been hospitalized and was being treated for a severe case of pneumonia.
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer.
Shares of Bed Bath & Beyond Inc. (NASDAQ:BBBY), declined -0.90% to $48.52, during its current trading session.
Bed Bath & Beyond Inc., declared preliminary information for the fiscal third quarter ended November 28, 2015, which comprised the Thanksgiving holiday in addition to the following two shopping days (Black Friday and Saturday), and offered an update on anticipated comparable sales from the startning of the fourth quarter through Christmas.
Although it is still in the process of its quarterly financial close, the Company now estimates net sales for the fiscal third quarter to have been about $3.0 billion, an improvement of about 0.3% from the prior year period. The Company had formerly modeled net sales to improvement by about 1.8% to 4.0%.
The Company now estimates third quarter comparable sales to have reduced by 0.4%, or relatively flat on a constant currency basis(a non-GAAP measure). The 0.4% unfavorable impact of foreign currency fluctuations is consistent with its previous model. Counting the impact of foreign currency fluctuations, the Company had formerly modeled comparable sales to improvement between 1.0% and 3.0%.
Bed Bath & Beyond Inc., together with its auxiliaries, operates a chain of retail stores. It sells a range of domestics merchandise, counting bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletops, basic housewares, general home furnishings, consumables, and certain juvenile products.
Finally, Rewalk Robotics Ltd (NASDAQ:RWLK), lost -4.26%, and is now trading at $16.21.
Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: Pep Boys-Manny Moe and Jack (PBY), Changyou.Com Ltd. (CYOU), Rewalk Robotics Ltd. (RWLK) and Aveo Pharmaceuticals Inc. (AVEO). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from recently’s reports comprise:
On Monday, December 21, 2015, the NASDAQ Composite ended at 4,968.92, up 0.93%, the Dow Jones Industrial Average advanced 0.72%, to finish the day at 17,251.62, and the S&P 500 closed at 2,021.15, up 0.78%.
- Pep Boys-Manny Moe and Jack’s stock edged higher by 6.92% to close Monday’s session at USD 16.85. The company’s shares oscillated between USD 16.51 and USD 16.85 in trade during the day. The stock recorded a trading volume of 0.94 million shares, which was below its 50-day daily average volume of 1.64 million shares but above its 52-week average volume of 0.68 million shares. Over the last three days Pep Boys-Manny Moe and Jack’s shares have advanced 4.98% and in the past one week the stock has moved up 4.01%. Furthermore, over the last three months the stock has gained 39.03% and in the past six months the shares have picked up 44.39%. The stock is trading at a price to book ratio of 1.56 which compares to a historical PB ratio close to 0.86. Additionally, the stock is trading at a price to cash flow ratio of 12.86 and price to sales ratio of 0.41.
- The stock of Changyou.Com Ltd. gained 5.80% to close Monday’s session at USD 25.00. The shares of the company moved in the range of USD 23.65 and USD 25.37 during the day. A trading volume of 0.88 million shares was recorded, which was greater than its 150-day daily average volume of 0.19 million shares and its 52-week average volume of 0.18 million shares. Over the last five days Changyou.Com Ltd.’s shares have advanced 25.57% and in the past one month the stock has gained a momentum of 15.21%. Additionally, over the last three months the stock has advanced 28.21% while in the past six months the shares have registered a loss of 18.62%. Further, the company is trading at a price to earnings ratio of 7.12 and a price to book ratio of 1.25. Further, the shares are trading at a price to cash flow ratio of 5.07 and price to sales ratio of 0.51.
- Rewalk Robotics Ltd.’s stock raised by 0.81% to close Monday’s session at USD 13.61. The company’s shares fluctuated in the range of USD 13.30 and USD 15.45 during the day. A total of 2.99 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.42 million shares and was above its 52-week average volume of 0.17 million shares. Over the last three days Rewalk Robotics Ltd.’s shares have advanced 126.83% and in the past one week the stock has moved up 133.45%. Furthermore, over the last three months, the stock has gained 45.95% and in the past six months, the shares have picked up 15.53%. The stock has been exhibiting some positive momentum and is trading above its 50-day and 200-day simple moving averages by 70.99% and 33.56%, respectively. Additionally, the stock has a Relative Strength Index of 83.47.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals. The company offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.